Stefan Kääb
University of Copenhagen
3 Papers
8 Citations
Stefan Kääb is an academic researcher from University of Copenhagen. The author has contributed to research in topics: Clinical endpoint & Placebo. The author has an hindex of 1, co-authored 3 publications.
Chat about Author
Papers
Effects of JNJ-54452840, an Anti-ò1 Receptor Antibody Cyclopeptidein Heart Failure Patients: A Randomized, Double-blind, Parallel-group,Phase-2 Pilot Study
Stefan Störk,Alexei N Plotnikov,Gary Peters,Brian E. Davies,Ivo Nnane,David A. Rivas,Fisseha Tesfaye,Stefan Kääb,Axel Bauer,Andreas Luchner,Martin Ungerer,Rol,Jahns,Martin J. Lohse,Georg Ertl +14 more
- 01 Aug 2016
TL;DR: No definitive statements on the efficacy of JNJ-5445280 in DCM patients with circulating anti-β1-Abs can be made, although centrally-assessed LVEF appeared to improve in the 80 mg dose group.
Present criteria for prophylactic ICD implantation: Insights from the EU-CERT-ICD (Comparative Effectiveness Research to Assess the Use of Primary ProphylacTic Implantable Cardioverter Defibrillators in EUrope) project
Markus Zabel,Simon Schlögl,Andrzej Lubiński,Jesper Hastrup Svendsen,Axel Bauer,Elena Arbelo,Sandro Brusich,David Conen,Iwona Cygankiewicz,Michael Dommasch,Panagiota Flevari,Jan Galuszka,Jim Hansen,Gerd Hasenfuß,Robert Hatala,Heikki V. Huikuri,Tuomas Kenttä,Tomasz Kucejko,Helge Haarmann,Markus Harden,Svetoslav Iovev,Stefan Kääb,Gabriela Kaliska,Andreas Katsimardos,Jarosław D. Kasprzak,Dariusz Qavoq,Lars Lüthje,Marek Malik,Tomáš Novotný,Nikola Pavlović,Péter Perge,Christian Röver,Georg Schmidt,Tchavdar N. Shalganov,Rajeeva Sritharan,Martin Svetlosak,Zoltán Salló,Janko Szavits-Nossan,Vassil Traykov,Bert Vandenberk,Vasil Velchev,Marc A. Vos,Stefan N. Willich,Tim Friede,Rik Willems,Béla Merkely,Christian Sticherling +46 more
TL;DR: The EU-CERT-ICD data will provide much needed information on the survival benefit of preventive ICD therapy and expand on previous prospective risk stratification studies which showed very good applicability of clinical parameters and advanced risk stratifiers in order to define patient subgroups with above or below average ICD benefit.
5
A method for assessing significant changes in serial ECG comparison
Siegfried Perz,Moritz Sinner,Roswitha Küfner,A. Pfeufer,Stefan Kääb +4 more
- 01 Sep 2008
TL;DR: The ECG changes derived from repeated records by this approach were significantly associated with the individualspsila history of cardiac disease.